Precision Optics Corporation, Inc. (POCI) Stock Price & Analysis

Precision Optics Corporation, Inc. (POCI) closed at USD 4.35 on Thursday, October 15, 2026, down 1.36% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 4.41; the Oct 15, 2026 session ranged USD 4.32–4.41 on volume of 8,554 shares. Market capitalization is $47.73M, with a 52-week range of USD 3.55–6.15 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.

Also available as compact Markdown for AI agents: nexqual.com/POCI.md

Key facts (POCI)

Analysts (POCI)

Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 8 (low 8, high 8).

Total return (dividends reinvested) (POCI)

1Y (from 2025-10-16)5Y (from 2021-10-11)
Total return+4.6%-34.1%
S&P 500 (SPY)+18.1%+85.1%
Per year+4.6%-8.0%
Volatility (annualized)50.5%42.2%
Max drawdown-34.3% (Feb 2026→Apr 2026)-48.0% (Jan 2022→Oct 2024)

Key Statistics (as of October 16, 2026 at 05:22 UTC)

PriceUSD 4.35
Change▼ 1.36% (down)
Previous CloseUSD 4.41
OpenUSD 4.37
Day RangeUSD 4.32 – 4.41
52-Week RangeUSD 3.55 – 6.15
Volume8,554 shares
Market Cap$47.73M
ExchangeNCM

Technical Analysis (POCI)

Nexqual's technical model rates POCI "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.

Overall SignalSELL
RSI (14)44.74 (neutral)
vs SMA50Below (USD 4.4)
MACD0.02 (positive)

Analyst Ratings (POCI)

Wall Street analysts rate POCI "Buy" based on 1 analysts, with a mean price target of USD 8 (range USD 8–8), per Nexqual as of October 16, 2026 at 05:22 UTC.

Consensus RatingBuy
Analyst Count1
Mean TargetUSD 8
High TargetUSD 8
Low TargetUSD 8
Buy / Hold / Sell1 / 0 / 0

Earnings (POCI)

Next Earnings Date2026-11-12
EPS EstimateUSD -0.13
Revenue Estimate$6.44M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD -0.01 vs est -0.06 ▲ beat

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Financials & Fundamentals (POCI)

Total Revenue$31.53M
Revenue Growth (latest quarter, YoY)+42.00%
Gross Margin+17.22%
Operating Margin-1.21%
Profit Margin-11.51%
ROE-22.26%
Debt / Equity0.2
Current Ratio2.28
Total Cash$9.84M
Total Debt$4.06M

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Financial Health Score (POCI)

Nexqual rates Precision Optics Corporation, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:22 UTC.

GrowthStrong — Revenue +42% YoY (latest Q)
ProfitabilityWeak — Not yet profitable — scaling phase
Balance SheetStrong — $10M cash vs $4M debt, net cash position
Cash FlowWeak — Operating cash flow -$2M (TTM)
EfficiencyCritical — ROE -22%, ROA -8.4%

Ownership (POCI)

Insider Ownership+19.87%
Institutional Ownership+41.66%
Shares Outstanding10.97M
Float8.27M
Short % of Float+0.43%

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Leadership (POCI)

Precision Optics Corporation, Inc. is led by Joseph N. Forkey (age 57), CEO, President, Treasurer & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.

CEO, President, Treasurer & DirectorJoseph N. Forkey (age 57)
CFO, Principal Accounting Officer & SecretaryWayne M. Coll (age 61)
Founder, Advisor to the CEO & Director EmeritusRichard E. Forkey (age 85)
Chief Operating OfficerJoseph Traut (age 53)
Senior Vice President of Sales and MarketingPeter Thier

Major Backers & Investors (POCI)

Notable institutional backers of Precision Optics Corporation, Inc. include Needham Investment Management, L.L.C., Needham Funds Inc-Needham Aggressive Growth Fund, MYDA Advisors LLC, according to Nexqual as of October 16, 2026 at 05:22 UTC.

Active Investors

InvestorStake
Needham Investment Management, L.L.C.29.63%
Needham Funds Inc-Needham Aggressive Growth Fund29.63%
MYDA Advisors LLC6.65%
Nantahala Capital Management, LLC4.97%
Wealthtrust Axiom, LLC4.62%
Morgan Stanley3.19%
HighTower Advisors, LLC2.21%
Fidelity0.98%

Index Funds (Passive)

FundStake
Vanguard Group11.56%
Geode Capital1.17%

Source: Nexqual, October 16, 2026 at 05:22 UTC.

Peers & Related Stocks

SymbolNamePriceChange
KMTSKestra Medical Technologies, LtUSD 28.68▲ 6.34%
XRAYDENTSPLY SIRONA Inc.USD 8.83▲ 3.76%
LMATLeMaitre Vascular, Inc.USD 83.16▲ 1.97%
ATRCAtriCure, Inc.USD 57.78▲ 1.6%
WRBYWarby Parker Inc.USD 24.59▼ 7.28%
PLSEPulse Biosciences, IncUSD 45.59▼ 6.08%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt